THE DEAL, AT A GLANCE
From the announcementReprogram Biosciences
What it doesReprogram Biosciences is a million in seed financing to develop mRNA-based Digital Health company focused on develop mRNA-based therapies for tumor cell reprogramming.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by Unshackled VenturesSearch company, 1517 FundSearch company, NaryaSearch companyFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedReprogram Biosciences raised $6M Seed, announced 2026-06-01From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersReprogram Biosciences' $6M Seed round is a small early-stage financing within an active Healthcare & Life Sciences funding market, positioning the company below most…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Reprogram Biosciences · Financing Record
Explore source-linked visual explanations for Reprogram Biosciences. Unsupported claims are withheld while source review continues.
Record 5056 · Recorded date: 2026-06-01
Explore company records →